BROOKSBSEBROOKS LAB LIMITEDHighNeutral
Announced Thu, 13 Aug · 19:50 IST

Q1 FY27 Results: Standalone profit declines, consolidated swings to loss

Revenue DeclinePat NegativeEbitda Margin CompressionResults View source PDFExplain this filing

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.8%1-day move
₹65.60
prior close
₹63.02
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0+0.8+0.8-7.8-8.7-9.9-8.1-8.5
Up moveDown movePending
AI summary

Brooks Laboratories Board approved Q1 FY27 results. Standalone revenue fell to Rs 2,296 lakhs from Rs 2,551 lakhs year on year. Standalone profit after tax dropped sharply to Rs 141.86 lakhs from Rs 265 lakhs. Consolidated results swung to a loss of Rs 178.69 lakhs versus a profit of Rs 958 lakhs last year, due to a Rs 320.55 lakh share of losses from joint venture Brooks Steriscience, which posted a loss of Rs 654 lakhs on revenue of Rs 1,751 lakhs. EPS stood at Rs 0.48 standalone and negative Rs 0.61 consolidated.

Likely market impact

Weak quarter: standalone profits nearly halved year on year and consolidated slipped into loss due to drag from joint venture Brooks Steriscience.